Tomic, Svetlana http://orcid.org/0000-0002-1613-3831
Kuric, Tihana Gilman
Popovic, Zvonimir
Zubonja, Tea Mirosevic
Article History
Received: 13 February 2021
Accepted: 14 May 2021
First Online: 20 May 2021
Declarations
:
: Svetlana Tomic received speaking fee from AbbVie d.o.o., Pliva Hrvatska d.o.o., Phoenix Pharmacia d.o.o., Sanofi-Aventis Croatia d.o.o., Novartis Hrvatska d.o.o., Fresenius Kabi d.o.o., Makpharm d.o.o., Medis Adria d.o.o., and Merz Pharmaceuticals GmbH and has received travel support for congress from Medis Adria d.o.o.; Tihana Gilman Kuric received speaking fee from Novartis Hrvatska d.o.o. and has received travel support for congress from Medis Adria d.o.o. and Makpharm d.o.o; Zvonimir Popovic received speaking fee from Novartis Hrvatska d.o.o; Tea Mirosevic Zubonja received speaking fee from Novartis Hrvatska d.o.o, Roche d.o.o., Pliva Hrvatska d.o.o., and Merck d.o.o.
: Approval was obtained from the Ethics committee of Osijek University Hospital Center. The procedures used in this study adhere to the tenets of the Declaration of Helsinki. Informed consent was obtained from all individual participants included in the study.